-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on AC Immune, Lowers Price Target to $12

Benzinga·05/01/2025 12:49:29
Listen to the news
HC Wainwright & Co. analyst Andrew Fein maintains AC Immune (NASDAQ:ACIU) with a Buy and lowers the price target from $16 to $12.